Stop funding expensive pneumonia vaccine, MSF urges vaccine alliance

Gavi, the Vaccine Alliance, which is part funded by the UK, should stop giving Pfizer and GlaxoSmithKline special funding for the pneumonia vaccine and instead focus on finding a cheaper version, Médecins Sans Frontières (MSF) has urged.1

MSF said that the two drug companies had “already earned more than their fair share” of subsidies, as well as “billions made from global sales,” and called for Gavi to use its remaining funds on a new manufacturer offering a more affordable version of the pneumonia vaccine.

Pfizer and GSK are currently …